20/20 Biolabs is trading 10.6% up at $0.47 as improving market sentiment drives a rotation back into higher-risk small-cap names.
- Major U.S. indices have gained over 1% today, signaling a strong risk-on tone across equities following several volatile sessions.
- There are no fresh company-specific headlines, earnings, or deal announcements driving today's price action.